Abstract -Retinoids are very effective compounds for the control of both cellular differentiation and cellular proliferation. New synthetic analogs show pronounced activity in suppressing experimental carcinogenesis jji !.L.Q by inhibiting the development of the malignant phenotype in a non-cytotoxic manner. Beside the extensive use of retinoids in dermatology they are currently being tested for the prevention and therapy of cancerous diseases in man. Whether increased consumption of 13-carotene, the precursor of natural retinoids, can prevent cancer is being evaluated in clinical intervention trials.
INTRODUCTION
The naturally occurring retinoids (the term retinoid is applied to retinol and its natural and synthetic congeners designed to exhibit at least one of the biological properties of retinol and its metabolites) ultimately all have their origin in a small number of plant carotenoids -predominantly 13-carotene -since animals are incapable of synthesis of vitamin A-active substances having an isoprenoidal substructure. 13-Carotene is metabolized mainly in the intestinal mucosa by two soluble enzyme systems, to give retinol. Retinoids: some natural carotenoid metabolites . 713
Uowever before any structure-specifity relationship is proposed in this way one should keep in mind that areas are difficult to demarcate in which only retinoic acid can effect a biological response since retinol and retinal are oxidized invivo to retinoic acid. Retinol is transported from the liver to target tissues in a protein-protein complex consisting of molar amounts of thyroxine, transthyretin and retinol-binding protein (RBP) . Human RBP is a single polypeptide chain with 182 aminoacid residues, whose sequence has already been determined; refined X-ray analyses may be expected in the near future. It has proved possible to isolate RBP from serum of various other species and the characteristics of these proteins show great similarities to one another. It is remarkable that this principle has been so strictly preserved in the course of evolution; this once again demonstrates the importance of plasma-circulating retinol-binding protein for adequate supply of retinoids to a specific organ site (Ref. 19 ).
Retinoids: some natural carotenoid metabolites .
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The introduction of the Wittig reacion, shortly after its discovery, into retinoid and On reading very comprehensive review articles on how to test the biological properties of a given new retinoidal structure one gains the impression that in reality we have no lack of standardized systems for determining the activity of a novel structure. The situation is less favorable when it comes to rapidly performable and reliable assay systems to give information on the specific toxicology of a retinoid. In this area, development work is essential, since chemoprevention is achievable only with those retinoids which can be administered over a long period, with a high degree of safety. For this reason, the intervention trials currently being carried out with 13-carotene deserve particu'ar attention, since no adverse effects at all would be expected with this preretinoid. If visible hypercarotenemia occurs, then this is an undoubted and non-dangerous symptom of too high a dosage. In addition, these investigations may possibly augur a new use of carotenoids in medicine, based on the ability of 13-carotene to quench singlet oxygen and to trap radicals, leading to highly conjugated, fairly unreactive species. This ability of 13-carotene is already being used in the protection of light-sensitive patients. These subjects have to be treated with large doses of 13-carotene, and no remarkable adverse effect has been reported.
